Publication

Deprescribing for frail older people - Learning from the case of Mrs. Hansen

Granas, A. G., Stendal Bakken, M., Ruths, S. & Taxis, K., Jun-2018, In : Research in Social and Administrative Pharmacy. 14, 6, p. 612-616 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Granas, A. G., Stendal Bakken, M., Ruths, S., & Taxis, K. (2018). Deprescribing for frail older people - Learning from the case of Mrs. Hansen. Research in Social and Administrative Pharmacy, 14(6), 612-616. https://doi.org/10.1016/j.sapharm.2017.07.003

Author

Granas, Anne Gerd ; Stendal Bakken, Marit ; Ruths, Sabine ; Taxis, Katja. / Deprescribing for frail older people - Learning from the case of Mrs. Hansen. In: Research in Social and Administrative Pharmacy. 2018 ; Vol. 14, No. 6. pp. 612-616.

Harvard

Granas, AG, Stendal Bakken, M, Ruths, S & Taxis, K 2018, 'Deprescribing for frail older people - Learning from the case of Mrs. Hansen', Research in Social and Administrative Pharmacy, vol. 14, no. 6, pp. 612-616. https://doi.org/10.1016/j.sapharm.2017.07.003

Standard

Deprescribing for frail older people - Learning from the case of Mrs. Hansen. / Granas, Anne Gerd; Stendal Bakken, Marit; Ruths, Sabine; Taxis, Katja.

In: Research in Social and Administrative Pharmacy, Vol. 14, No. 6, 06.2018, p. 612-616.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Granas AG, Stendal Bakken M, Ruths S, Taxis K. Deprescribing for frail older people - Learning from the case of Mrs. Hansen. Research in Social and Administrative Pharmacy. 2018 Jun;14(6):612-616. https://doi.org/10.1016/j.sapharm.2017.07.003


BibTeX

@article{7dee32286a234ce28fdf148997ed18da,
title = "Deprescribing for frail older people - Learning from the case of Mrs. Hansen",
abstract = "Drug treatment is often an essential part in treatment and prevention of diseases in older people, but there is much concern about inappropriate medication use. This paper aims to describe the complexity of medication safety issues and clinical judgments when optimizing prescribing in older individuals. It uses the case of Mrs. Hansen, an aged nursing home resident, to illustrate the facilitators and barriers of this process. With decreasing life expectancy, medication use should shift from cure to care, focusing on symptomatic treatment to increase the patient's well-being. In Mrs. Hansen's case, the number of (potentially) dangerous medications were reduced, and non-pharmacological alternatives were considered. There were some medicines added, as underprescribing can also be a problem in older people. Deprescribing long-standing treatment can be interpreted by the patient and family as {"}giving up hope{"}. More clinical evidence and practical communication tools are needed to guide deprescribing decisions, taking medical and patient-centered priorities into account. Studies evaluating such interventions should select outcome measures that are particularly relevant for frail old individuals. (c) 2017 Elsevier Inc. All rights reserved.",
keywords = "NURSING-HOME RESIDENTS, CONTROLLED-TRIAL, MEDICATION, POLYPHARMACY, PHARMACIST, PREVENTION, CRITERIA, OUTCOMES, PATIENT, ADULTS",
author = "Granas, {Anne Gerd} and {Stendal Bakken}, Marit and Sabine Ruths and Katja Taxis",
note = "Copyright {\textcopyright} 2017. Published by Elsevier Inc.",
year = "2018",
month = jun,
doi = "10.1016/j.sapharm.2017.07.003",
language = "English",
volume = "14",
pages = "612--616",
journal = "Research in Social and Administrative Pharmacy",
issn = "1934-8150",
publisher = "ELSEVIER SCIENCE INC",
number = "6",

}

RIS

TY - JOUR

T1 - Deprescribing for frail older people - Learning from the case of Mrs. Hansen

AU - Granas, Anne Gerd

AU - Stendal Bakken, Marit

AU - Ruths, Sabine

AU - Taxis, Katja

N1 - Copyright © 2017. Published by Elsevier Inc.

PY - 2018/6

Y1 - 2018/6

N2 - Drug treatment is often an essential part in treatment and prevention of diseases in older people, but there is much concern about inappropriate medication use. This paper aims to describe the complexity of medication safety issues and clinical judgments when optimizing prescribing in older individuals. It uses the case of Mrs. Hansen, an aged nursing home resident, to illustrate the facilitators and barriers of this process. With decreasing life expectancy, medication use should shift from cure to care, focusing on symptomatic treatment to increase the patient's well-being. In Mrs. Hansen's case, the number of (potentially) dangerous medications were reduced, and non-pharmacological alternatives were considered. There were some medicines added, as underprescribing can also be a problem in older people. Deprescribing long-standing treatment can be interpreted by the patient and family as "giving up hope". More clinical evidence and practical communication tools are needed to guide deprescribing decisions, taking medical and patient-centered priorities into account. Studies evaluating such interventions should select outcome measures that are particularly relevant for frail old individuals. (c) 2017 Elsevier Inc. All rights reserved.

AB - Drug treatment is often an essential part in treatment and prevention of diseases in older people, but there is much concern about inappropriate medication use. This paper aims to describe the complexity of medication safety issues and clinical judgments when optimizing prescribing in older individuals. It uses the case of Mrs. Hansen, an aged nursing home resident, to illustrate the facilitators and barriers of this process. With decreasing life expectancy, medication use should shift from cure to care, focusing on symptomatic treatment to increase the patient's well-being. In Mrs. Hansen's case, the number of (potentially) dangerous medications were reduced, and non-pharmacological alternatives were considered. There were some medicines added, as underprescribing can also be a problem in older people. Deprescribing long-standing treatment can be interpreted by the patient and family as "giving up hope". More clinical evidence and practical communication tools are needed to guide deprescribing decisions, taking medical and patient-centered priorities into account. Studies evaluating such interventions should select outcome measures that are particularly relevant for frail old individuals. (c) 2017 Elsevier Inc. All rights reserved.

KW - NURSING-HOME RESIDENTS

KW - CONTROLLED-TRIAL

KW - MEDICATION

KW - POLYPHARMACY

KW - PHARMACIST

KW - PREVENTION

KW - CRITERIA

KW - OUTCOMES

KW - PATIENT

KW - ADULTS

U2 - 10.1016/j.sapharm.2017.07.003

DO - 10.1016/j.sapharm.2017.07.003

M3 - Article

C2 - 28733142

VL - 14

SP - 612

EP - 616

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

SN - 1934-8150

IS - 6

ER -

ID: 45972450